Trypanosoma cruzi: in vitro activity of Epoxy-?-Lap, a derivative of ?-lapachone, on trypomastigote and amastigote forms

Título:

Trypanosoma cruzi: in vitro activity of Epoxy-?-Lap, a derivative of ?-lapachone, on trypomastigote and amastigote forms

Autor:

Saulo Cabral Bourguignon

Ano:

2009

DOI:

10.1016/j.exppara.2009.03.002

Revista:

Experimental Parasitology

ISSN:

00144894

Home:

[doi:10.1016/j.exppara.2009.03.002]

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

'Metabolic Alteration of Trypanosoma cruzi during Differentiation of Epimastigote to Trypomastigote Forms'

Application of the enterprise diagnosis method in healthcare: an evaluation study in three emergency care units in the state of São Paulo - Brazil

Biocinais: recurso com licenças abertas em ambiente ava auxilia na divulgação de conhecimento científico bilingue em cursos de Pós-Graduações

Manual de biossegurança em Saúde: Vídeos para comunidade surda brasileira com novos termos em Libras empregados no cotidiano da pandemia do novo coronavírus

A importância da capacitação em biossegurança para profissionais surdos:

Systematic review and meta-analysis of the use of lean methods and tools in healthcare services: an alternative to improve care during the pandemic

Natural products from marine red and brown algae against Trypanosoma cruzi

Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas' disease

The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis

Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2--oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment